Cargando…

Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents

One obstacle to the successful delivery of nanodrugs into solid tumors is the heterogeneity of an enhanced permeability and retention (EPR) effect as a result of occluded or embolized tumor blood vessels. Therefore, the augmentation of the EPR effect is critical for satisfactory anticancer nanomedic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Jun, Islam, Rayhanul, Islam, Waliul, Yin, Hongzhuan, Subr, Vladimir, Etrych, Tomas, Ulbrich, Karel, Maeda, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680399/ https://www.ncbi.nlm.nih.gov/pubmed/31315251 http://dx.doi.org/10.3390/pharmaceutics11070343

Ejemplares similares

EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect
por: Islam, Waliul, et al.
Publicado: (2021)

Singlet Oxygen In Vivo: It Is All about Intensity
por: Hackbarth, Steffen, et al.
Publicado: (2022)

Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines
por: Šubr, Vladimír, et al.
Publicado: (2022)

Polymer theranostics with multiple stimuli-based activation of photodynamic therapy and tumor imaging
por: Tavares, Marina Rodrigues, et al.
Publicado: (2023)

Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin
por: Fang, Jun, et al.
Publicado: (2015)

HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021)

The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects
por: Maeda, Hiroshi
Publicado: (2021)

Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate
por: Duncan, Ruth, et al.
Publicado: (2013)

Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies
por: Yanazume, Shintaro, et al.
Publicado: (2022)

Tumor Environment-Responsive Hyaluronan Conjugated Zinc Protoporphyrin for Targeted Anticancer Photodynamic Therapy
por: Gao, Shanghui, et al.
Publicado: (2021)

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
por: Lammers, T, et al.
Publicado: (2008)

Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity
por: Yin, Hongzhuan, et al.
Publicado: (2014)

Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery
por: Dhaliwal, Alexander, et al.
Publicado: (2019)

Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
por: Kim, Jinseong, et al.
Publicado: (2023)

Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation
por: Libánská, Alena, et al.
Publicado: (2020)

Singlet Oxygen In Vivo: It Is All about Intensity—Part 2
por: Hackbarth, Steffen, et al.
Publicado: (2023)

The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
por: Shi, Yang, et al.
Publicado: (2020)

EPR Effect-Based Tumor Targeted Nanomedicine: A Promising Approach for Controlling Cancer
por: Fang, Jun
Publicado: (2022)

Extracts of Phellinus linteus, Bamboo (Sasa senanensis) Leaf and Chaga Mushroom (Inonotus obliquus) Exhibit Antitumor Activity through Activating Innate Immunity
por: Fang, Jun, et al.
Publicado: (2020)

The development of a high-affinity conformation-sensitive antibody mimetic using a biocompatible copolymer carrier (iBody)
por: Blažková, Kristyna, et al.
Publicado: (2021)

Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study
por: Kudláčová, Júlia, et al.
Publicado: (2020)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins
por: Bachtarzi, Houria, et al.
Publicado: (2011)

Past, Present, and Future of Anticancer Nanomedicine
por: Kim, Kyungeun, et al.
Publicado: (2020)

The Potential Role of Sildenafil in Cancer Management through EPR Augmentation
por: Haider, Mohamed, et al.
Publicado: (2021)

Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control
por: Shen, Yao An, et al.
Publicado: (2015)

Zebrafish as a Model for Anticancer Nanomedicine Studies
por: Al-Thani, Hissa F., et al.
Publicado: (2021)

Recent insights on nanomedicine for augmented infection control
por: Singh, Sima, et al.
Publicado: (2019)

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
por: Tavares, Marina R., et al.
Publicado: (2021)

Carbon monoxide poisoning
por: Kinoshita, Hiroshi, et al.
Publicado: (2020)

Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release
por: Stifter, Julia, et al.
Publicado: (2017)

Traceless Bioresponsive Shielding of Adenovirus Hexon with HPMA Copolymers Maintains Transduction Capacity In Vitro and In Vivo
por: Prill, Jan-Michael, et al.
Publicado: (2014)

Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control [Corrigendum]
Publicado: (2017)

Electrochemotherapy of Deep-Seated Tumors: State of Art and Perspectives as Possible “EPR Effect Enhancer” to Improve Cancer Nanomedicine Efficacy
por: Bonferoni, Maria Cristina, et al.
Publicado: (2021)

Benzothiazole derivatives as anticancer agents
por: Irfan, Ali, et al.
Publicado: (2019)

Biological evaluation of new potential anticancer agent for tumour imaging and radiotherapy by two methods: (99m)Tc-radiolabelling and EPR spectroscopy
por: Karamalakova, Yanka, et al.
Publicado: (2014)

Xth EPR Workshop on Applications of EPR in Biology and Medicine
por: Sarna, Tadeusz, et al.
Publicado: (2017)

Nanocomposites as biomolecules delivery agents in nanomedicine
por: Bamburowicz-Klimkowska, Magdalena, et al.
Publicado: (2019)

EPR Everywhere
por: Biller, Joshua R., et al.
Publicado: (2021)

Polymeric Core–Shell Combinatorial Nanomedicine for Synergistic Anticancer Therapy
por: Shanavas, Asifkhan, et al.
Publicado: (2019)

Inner ear barriers to nanomedicine-augmented drug delivery and imaging()
por: Zou, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dredfpaa103254t1lh47abkvhr